Skip to main content
915 TLDR
Health
1 read

Growing Use of GLP-1 Medications for Weight Loss in El Paso

KTSM••Andy Morgan
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

The use of GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, is on the rise among Americans seeking weight loss solutions, with a notable increase in El Paso. Currently, about 11% of U.S. adults, equating to approximately 28 million individuals, are utilizing these medications. While these drugs show effectiveness in aiding weight loss, potential side effects and risks are important considerations for users. As the trend continues, residents should be informed about the benefits and drawbacks of these treatments to make educated health decisions.

Key Details: • 11% of U.S. adults are using GLP-1 medications for weight loss. • Approximately 28 million Americans are currently taking these medications. • Common GLP-1 medications include Ozempic, Wegovy, and Mounjaro. • Potential side effects and risks should be discussed with healthcare providers.

el-paso health weight-loss medications glp-1

People & Organizations

El Paso

Related Articles

KVIA•1h ago

Rising Cyclospora Outbreak Raises Concerns About Kids' Vegetable Intake

A recent outbreak of the cyclospora parasite in the U.S. has raised alarm among parents about the safety of fresh produce, particularly for children. A study published on July 8 revealed that children worldwide, including those in the U.S., are not consuming enough fruits and vegetables, with older children and teenagers showing a significant decline in intake. While younger children average nearly three servings a day, this drops to fewer than two servings as they grow older. Experts emphasize the importance of maintaining healthy eating habits early in life to prevent chronic diseases later on. Parents are encouraged to continue offering fruits and vegetables despite their children's pickiness and to involve them in food preparation.

Health
1 min read
KVIA•6h ago

Understanding Medication Formularies: A Key to Cost-Effective Healthcare in El Paso

Navigating health insurance plans can be challenging, especially when it comes to understanding medication formularies. These formularies are lists of covered medications that can significantly impact your out-of-pocket costs. They are organized into tiers, with lower tiers typically offering lower copays. It's essential for El Paso residents to review their health plan's formulary to ensure their necessary prescriptions are covered and to avoid unexpected expenses. If a medication isn't listed, patients may need to request an exception or pay out of pocket. Knowing how to utilize this tool can lead to better healthcare decisions and savings.

Health
1 min read
KVIA•6h ago

Sardinia's Centenarians: Men and Women Live Equally Long in Unique Villages

In Sardinia's Blue Zone, the traditional gender longevity gap nearly disappears, with men reaching 100 years at almost the same rate as women. This phenomenon is particularly evident in the village of Villagrande Strisaili, where men slightly outnumber women among centenarians, a rarity globally. Research indicates that the gut microbiome plays a crucial role in this longevity, particularly a microbe called Akkermansia muciniphila, which is significantly more abundant in Sardinian centenarians compared to younger adults. This discovery highlights the importance of gut health and diet in aging, making it a topic of interest for further studies in longevity.

Health
1 min read
KVIA•6h ago

Majority of Americans Support FDA Accessibility for Popular Peptides

A recent survey by Hone Health reveals that 83% of U.S. adults familiar with peptides advocate for the FDA to allow licensed compounding pharmacies to produce seven specific peptides with a physician's prescription. The Pharmacy Compounding Advisory Committee (PCAC) will meet on July 23-24, 2026, to discuss adding these peptides to the 503A Bulks List, which would enable safer access for consumers currently relying on unregulated sources. Dr. Abid Husain emphasizes that regulated access could mitigate risks associated with gray-market peptides, which often contain harmful impurities. The decision from the FDA is expected by late 2026, with 39% of potential users indicating that reclassification would encourage them to try peptides.

Health
1 min read